A Synergistically Enhanced Near-Infrared ESIPT Fluorescent Probe for High-Performance In Situ Imaging of Cellular Apoptosis
Molecular Pharmaceutics · 07.07.2025 · 22 (7) · 4321-4329
DOI: 10.1021/acs.molpharmaceut.5c00615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 11.06.2025. Verfasst von Qian Lei und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Third Xiangya Hospital, Central South University, Changsha 410013, China. Hauptthemen laut MEDLINE: Apoptosis, Fluorescent Dyes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China, Central South University Research Programme of Advanced Interdisciplinary Studies.
Abstract (Originalsprache)
Monitoring apoptotic progression is critical for tracking disease development and evaluating therapeutic interventions. Fluorescent probes that integrate aggregation-induced emission (AIE) and excited-state intramolecular proton transfer (ESIPT) offer some advantages, including large Stokes shifts, high quantum yields in the aggregated state, and strong photostability. In this study, we developed an ESIPT-based fluorescent probe, ABTT-DEVD, with AIE properties for the highly sensitive detection of caspase-3 and real-time imaging of apoptosis. The probe design incorporates a hydrophilic DEVD peptide substrate linked to a hydrophobic ESIPT fluorophore. Caspase-3-mediated cleavage induces a significant change in water solubility, leading to strong fluorescence enhancement with an ultralow detection limit of 1.2 pM. Molecular docking studies corroborate the specific interaction of the DEVD peptide with the caspase-3 active site. Furthermore, ABTT-DEVD enabled the visualization of endogenous caspase-3 activity in living cells, facilitating the evaluation of antitumor drug efficacy. The probe's effectiveness in tracking apoptosis progression is further supported by fluorescence data and flow cytometry analysis, underscoring its potential as a valuable tool for apoptosis monitoring in biomedical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Xiangya Hospital, Central South University, Changsha 410013, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
- The Molecular Imaging Research Center, Central South University, Changsha 410013, China.
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410007, China.
ORCID-Profile: Wenbin Zeng
Förderung
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
- Central South University Research Programme of Advanced Interdisciplinary Studies
Zitieren
APA
Lei, Q., Cheng, X., Chen, Q., Ma, X., Wang, W., Rong, P., Feng, B., Zhang, S., & Zeng, W. (2025). A Synergistically Enhanced Near-Infrared ESIPT Fluorescent Probe for High-Performance In Situ Imaging of Cellular Apoptosis. Molecular Pharmaceutics, 22(7), 4321-4329. https://doi.org/10.1021/acs.molpharmaceut.5c00615
Vancouver
Lei Q, Cheng X, Chen Q, Ma X, Wang W, Rong P, et al. A Synergistically Enhanced Near-Infrared ESIPT Fluorescent Probe for High-Performance In Situ Imaging of Cellular Apoptosis. Molecular Pharmaceutics. 2025;22(7):4321-4329. doi:10.1021/acs.molpharmaceut.5c00615
BibTeX
@article{Lei2025,
author = {Lei, Qian and Cheng, Xiang and Chen, Qian and Ma, Xiaoqian and Wang, Wei and Rong, Pengfei and Feng, Bin and Zhang, Shengwang and Zeng, Wenbin},
title = {A Synergistically Enhanced Near-Infrared ESIPT Fluorescent Probe for High-Performance In Situ Imaging of Cellular Apoptosis},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {7},
pages = {4321--4329},
doi = {10.1021/acs.molpharmaceut.5c00615}
}
EUVIMED